Benefits and risks of using erythropoiesis-stimulating agents (ESAs) in lung cancer patients: Study-level and patient-level meta-analyses

✍ Scribed by Vansteenkiste, Johan; Glaspy, John; Henry, David; Ludwig, Heinz; Pirker, Robert; Tomita, Dianne; Collins, Helen; Crawford, Jeffrey

• Book ID: 119320745
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 670 KB
• Volume: 76
• Category: Article
• ISSN: 0169-5002
• DOI: 10.1016/j.lungcan.2011.12.015